Trump Administration Reclaims U.S. Manufacturing With Investments
President Trump and his administration have used tariffs and corporate dealmaking over the past eleven months to onshore manufacturing and technology investments in the United States. Companies including IBM ($150 billion), Micron ($200 billion), Bristol Myers Squibb ($40 billion) and Pfizer/Moderna (about $400 billion) have pledged investments, contributing to nearly $1 trillion in inflows this year, Commerce Secretary Howard Lutnick says.
Key Points
- 1Commands large corporate commitments including IBM $150B, Micron $200B, Pfizer/Moderna ~$400B, BMS $40B
- 2Uses tariffs and dealmaking to prioritize U.S. industry, driving near-$1 trillion in inflows this year
- 3Signals potential long-term reindustrialization, affecting supply chains, national security, and domestic R&D investments
Scoring Rationale
Major corporate onshoring and tariffs signal wide industry impact; credibility limited by opinionated sourcing and lack of independent verification.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
